+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urological Disorders Drugs Market Research Reports

From
Hemorrhagic Cystitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hemorrhagic Cystitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Complicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Complicated Urinary Tract Infections - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Interstitial Cystitis - Pipeline Insight, 2025 - Product Thumbnail Image

Interstitial Cystitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Nocturia - Pipeline Insight, 2025 - Product Thumbnail Image

Nocturia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Urinary Tract Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Bladder Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Bladder Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Urinary Incontinence - Pipeline Insight, 2025 - Product Thumbnail Image

Urinary Incontinence - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cystitis- Pipeline Insight, 2025 - Product Thumbnail Image

Cystitis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Underactive Bladder (UAB)- Epidemiology Forecast-2034 - Product Thumbnail Image

Underactive Bladder (UAB)- Epidemiology Forecast-2034

  • Report
  • December 2024
  • 70 Pages
  • Global
From
From
From
Uncomplicated Urinary Tract Infection - Epidemiology Forecast - 2032 - Product Thumbnail Image

Uncomplicated Urinary Tract Infection - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 74 Pages
  • Global
From
Urinary Incontinence - Epidemiology Forecast to 2032 - Product Thumbnail Image

Urinary Incontinence - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Cystinuria Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Cystinuria Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Genitourinary Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Genitourinary Drugs Market Report and Forecast 2024-2032

  • Report
  • May 2024
  • 140 Pages
  • Global
From
From
Cystinuria Market Report and Forecast 2025-2034 - Product Thumbnail Image

Cystinuria Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
Loading Indicator

The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them. Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more